Document is current
Any future updates will be listed below
-
Authors
El Abiead, Yasin
Rutz, Adriano https://orcid.org/0000-0003-0443-9902
Zuffa, Simone https://orcid.org/0000-0001-7237-3402
Amer, Bashar
Xing, Shipei https://orcid.org/0000-0001-6227-6959
Brungs, Corinna https://orcid.org/0000-0002-2571-5235
Schmid, Robin
Correia, Mario S. P.
Caraballo-Rodriguez, Andres Mauricio
Zarrinpar, Amir
Mannochio-Russo, Helena
Witting, Michael https://orcid.org/0000-0002-1462-4426
Mohanty, Ipsita
Pluskal, Tomáš https://orcid.org/0000-0002-6940-3006
Bittremieux, Wout https://orcid.org/0000-0002-3105-1359
Knight, Rob
Patterson, Andrew D.
van der Hooft, Justin J. J. https://orcid.org/0000-0002-9340-5511
Böcker, Sebastian https://orcid.org/0000-0002-9304-8091
Dunn, Warwick B. https://orcid.org/0000-0001-6924-0027
Linington, Roger G. https://orcid.org/0000-0003-1818-4971
Wishart, David S. https://orcid.org/0000-0002-3207-2434
Wolfender, Jean-Luc https://orcid.org/0000-0002-0125-952X
Fiehn, Oliver https://orcid.org/0000-0002-6261-8928
Zamboni, Nicola https://orcid.org/0000-0003-1271-1021
Dorrestein, Pieter C. https://orcid.org/0000-0002-3003-1030
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIH U24DK133658)
- License Information
-
More Information
Article History
First Online: 28 February 2025
Competing interests
: P.C.D. is an advisor to and holds equity in Cybele, BileOmix and Sirenas and is a scientific co-founder of, is advisor to, holds equity in and/or received income from Ometa, Enveda and Arome with prior approval by the University of California, San Diego. P.C.D. also consulted for DSM Animal Health in 2023. J.J.J.v.d.H. is member of the scientific advisory board of Naicons Srl., Milano, Italy and consults for Corteva Agriscience, Indianapolis, IN, USA. R.S. and T.P. are co-founders of mzio GmbH. A.Z. is a co-founder of and equity holder in Endure Biotherapeutics. R.K. is a scientific advisory board member and consultant for BiomeSense, Inc., has equity and receives income. He is a scientific advisory board member and has equity in GenCirq. He is a consultant for DayTwo and receives income. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. He is a cofounder of Micronoma, has equity and is a scientific advisory board member. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. The other authors declare no competing interests. S.B. is co-founder of Bright Giant.
